@ShahidNShah
AI will boost Workflow, Workforce Development and Patient Safety in 2025
Clinicians and other workers in the healthcare delivery chain are always looking for ways to improve workflow. Similarly, hospital and health system leadership always desire new ways to develop their workforce – the same people hunting for better workflow.And all of these executives, caregivers and workers want to ensure their organizations are operating at the very peak for patient safety. Nothing is more important.And it's these three areas of healthcare that Stacey Caywood, CEO of Wolters Kluwer Health, sees artificial intelligence boosting in 2025. She says these three areas – workflow, workforce development and patient safety – will benefit most this year from the application of various AI technologies.At Wolters Kluwer Health, Caywood has had responsibility for leading a global company that offers clinical technology and evidence-based systems that engage clinicians, patients, researchers and students.
Medigy Insights
In 2024, they saw the health tech sector really start to focus 2023's AI excitement into tangible systems that make clinicians' workdays easier and more productive. Tackling the clinician burnout epidemic has sharpened the focus of strategies behind many health AI technologies coming to market in 2025.According to the AMA, nearly half of U.S. doctors report suffering from burnout.While the burnout epidemic seems like a monolithic and systemic challenge, what has been remarkable to see is it is being addressed from a wide array of angles.
Continue reading at healthcareitnews.com
Make faster decisions with community advice
- FDA Updates Guidance on Pulse ox Devices Used in Healthcare
- HHS publishes AI Strategic Plan, with Guidance for Healthcare, Public health, Human Services
- DoD to Develop Scalable GenAI Testing Datasets
- How to Optimize Meeting Rooms for Hybrid Work in Healthcare
- Is Healthcare Doing Anything Well in Cybersecurity?
Next Article
-
DEA Plans to create a Special Telehealth Registration for Prescribers
The U.S. Drug Enforcement Agency has released its notice of proposed rulemaking for a framework to permit medically necessary controlled substances without an in-person visit without violating the …